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Abstract
Background: Lymphatic filariasis (LF) is one of the neglected tropical diseases targeted for global elimination by
2020 and to guide elimination efforts countries have, in recent years, conducted extensive mapping surveys.
Documenting the past and present distribution of LF and its environmental limits is important for a number of
reasons. Here, we present an initiative to develop a global atlas of LF and present a new global map of the limits of
LF transmission.
Methods: We undertook a systematic search and assembly of prevalence data worldwide and used a suite of
environmental and climatic data and boosted regression trees (BRT) modelling to map the transmission limits of LF.
Results: Data were identified for 66 of the 72 countries currently endemic and for a further 17 countries where LF
is no longer endemic. Our map highlights a restricted and highly heterogeneous distribution in sub-Saharan Africa,
with transmission more widespread in West Africa compared to east, central and southern Africa where pockets of
transmission occur. Contemporary transmission occurs across much of south and South-east Asia and the Pacific.
Interestingly, the risk map reflects environmental conditions suitable for LF transmission across Central and South
America, including the southern States of America, although active transmission is only known in a few isolated foci.
In countries that have eliminated LF, our predictions of environmental suitability are consistent with historical distribution.
Conclusions: The global distribution of LF is highly heterogeneous and geographically targeted and sustained control
will be required to achieve elimination. This first global map can help evaluate the progress of interventions and guide
surveillance activities.
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Background
Lymphatic filariasis (LF) is a mosquito-borne disease
which in its advanced forms can manifest as severe lym-
phoedema, hydrocele and elephantiasis [1]. The majority
of global cases are caused by Wuchereria bancrofti, with
Brugia malayi and B. timori as important local causes of
the disease in South-east Asia. These nematode parasites
are transmitted by various species of mosquito vectors
from the genera Anopheles, Aedes, Culex, Mansonia and
Ochlerotatus. LF is one of nine infectious diseases targeted
for global elimination [2]. The selection of LF for elimin-
ation was based on (i) the absence of animal reservoirs for
W. bancrofti (the most common form of LF) and only a
small animal reservoir for B. malayi (which occurs in
restricted foci) [3,4], (ii) the existence of effective and
practical interventions to interrupt transmission, and (iii)
availability of an accurate diagnostic tool [5]. The main
intervention strategy is mass drug administration (MDA)
with albendazole in combination with diethylcarbamazine
(DEC) (or ivermectin in countries where onchocerciasis
is endemic) to entire communities in districts where the
prevalence of LF is equal or more than 1% [6], supported
by vector control to reduce exposure to mosquitoes and
morbidity management to alleviate suffering and prevent
disability of those affected by the disease [7,8]. During the
last half century, several countries have successfully
eliminated LF, including Japan, China, South Korea, the
Solomon Islands, Egypt and Togo [9-13].
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A key component of national elimination programmes
is a detailed understanding of the geographical distribution
of LF so that all endemic areas can be targeted. Early
attempts to map the distribution of LF included detailed
literature reviews [14-20] or mapping at national or sub-
national levels [21-26]. Although useful for estimating the
global burden of LF [27], such national estimates belie the
highly focal distribution of LF [28-32] and cannot be used
to geographically target control. The mapping of LF has in
recent years been greatly facilitated by the use of simple
and rapid detection tests for W. bancrofti (antigen-based
test) and Brugia spp (antibody-based test), based on the
immuno-chromatographic test (ICT card test), which
avoids the need to collect blood at night and the time-
consuming preparation and examination of blood slides
[33-38]. By the end of 2012, 59 out of the 72 endemic
countries had completed national mapping surveys [39].
The results of these surveys highlight the marked within-
country geographical heterogeneity [26,40-46]. LF map-
ping is ongoing in the remaining endemic countries except
Eritrea, where it has not started yet [2].
To augment available field surveys, a number of recent
studies have sought to predict the distribution of LF on
the basis of climatic and environmental factors. This ap-
proach is predicated on the fact that W. bancrofti is in-
efficiently transmitted, requiring thousands of infective
bites to establish a patent infection [47], and as such LF
is only likely to occur where climatic conditions are suit-
able to support mosquito vector populations over ex-
tended time periods [14,48]. An early attempt to develop
a risk map for LF in Africa was by Lindsay and Thomas
in 2000, based on data from 32 studies using frequentist
logistic regression and coarse-resolution environmental
data [49]. More recently, Slater and Michael have used
maximum entropy ecological niche modelling [50] and
Bayesian model-based geostatistics [51] to predict the geo-
graphical occurrence and distribution of LF in Africa. Risk
maps using environmental factors or spatial interpolation
have also been developed at national or sub-national scales
in West Africa [52], Egypt [53] and India [54].
Building on this previous work, we describe a new initia-
tive to develop a global atlas of LF infection, which aims
to collate all available survey data into a single, freely avail-
able resource and describe the historical and contempor-
ary distribution of LF. Understanding these distributions
has more than cartographic interest. First, changes in the
epidemiology of LF over time can be quantified. Second,
factors underlying such changes can be investigated in an
effort to assess the degree to which changes are directly
related to the scaling-up of interventions or other factors.
Third, analysis of the historical risks of infection prior to
large-scale intervention can be used to quantify the inter-
vention needs required to reach programme goals [55],
identify factors that contribute to the persistence of
transmission, help define the intrinsic sensitivity (receptiv-
ity) of transmission to future changes in the intensity and
frequency of control [56-59], and provide a basis to stratify
surveillance activities. The specific aims of the present
paper are (i) to detail the methods and approaches used
to develop the database, (ii) to map historical and con-
temporary distributions of LF, and (iii) to delineate the
global transmission limits of LF. The work is conducted
within the context of the Global Atlas of Helminth In-
fections (www.thiswormyworld.org) [60] which aims to
develop a suite of geographical resources and tools for
neglected tropical diseases (NTDs).
Methods
Approaches to the diagnosis and mapping of LF
Night collection and examination of blood slides is consid-
ered the gold standard approach for detecting microfi-
lariae. However, the sensitivity of this approach crucially
relies on the volume of blood sampled [61]. Other para-
sitological methods, such as Knott’s concentration test and
membrane filtration [62], increase the sensitivity of diag-
nosis but are prohibitively expensive for routine use. Alter-
natively, the presence of W. bancrofti antigenaemia can be
detected using the ICT card test [33-35] and presence of
specific IgG4 antibodies to Brugia spp can be detected
using the Brugia Rapid™ test [36-38]. Surveys for the map-
ping of LF have been based on a variety of sampling de-
signs, including the rapid geographical assessment of
Bancroftian filariasis (RAGFIL) method [29,63], lot quality
assurance sampling [64,65], population-based household
surveys [66] and sentinel site surveys [43,67,68], with the
choice of survey methodology dependent on available re-
sources and the stage of the control programme [69].
Identification of survey data
Our approach to identify suitable data follows that de-
veloped originally by Norman Stoll in his seminal work
This Wormy World in 1947 [70], and adopted by efforts
to map malaria [71,72] as well as soil-transmitted hel-
minth and schistosome infections [73-75]. Relevant data
on the prevalence of LF were identified through a com-
bination of (i) structured searches of electronic biblio-
graphic databases, (ii) additional searches of the ‘grey’
literature, including unpublished surveys and govern-
ment and international archives, and (iii) direct contact
with researchers and control programme managers. The
online databases PubMed, MEDLINE, EMBASE and
SCOPUS were used to identify relevant studies for LF,
using the following predefined Medical Subject Heading
(MeSH) terms: lymphatic filariasis, bancroftian filariasis,
Wuchereria bancrofti, Brugia malayi, Brugia timori, ma-
layan filariasis AND current and former country names.
All permutations of MeSH terms were entered, with
no restrictions on language or date of publication. The
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abstracts of returned articles were reviewed and if they did
not explicitly report prevalence data, they were discarded.
When the abstract was not available, pre-selection was
made according to the title. Authors were contacted when
additional information was required or when data needed
to be disaggregated. Studies were included if they pro-
vided: (i) the number of people surveyed, (ii) the number
of LF positive cases, (iii) details about the methodology of
diagnosis and (iv) details of the specific site where they
were conducted, regardless of the administrative level.
Surveys reporting only prevalence data without provision
of the denominator were also included as these can be
used to delineate the limits of transmission. Baseline data
from clinical and diagnostic trials fulfilling the inclusion
criteria were abstracted, whereas surveys carried out at
hospitals, prisons, mental institutions or military facilities
were excluded.
Data were extracted into a customized Microsoft Ac-
cess (Microsoft 2007) database and linked to an identical
SQL Server database. Abstracted data included three
types of information: (i) epidemiological data on survey
method, type of diagnostic method, dates, age range and
gender of targeted people, time of survey (day or night),
ongoing control activities and number of MDA rounds
undertaken in the area at the time of survey, number of
people sampled, number of positive individuals and preva-
lence, diagnostic method used, blood sampling volumes
for detection of microfilaraemia and, where available, mor-
bidity data based on hydrocele and/or lymphoedema; (ii)
each record was assigned a unique identifier which linked
the record to the source publication which was included
in an Endnote library (Thomson Reuters 2010), with a pdf
copy of each publication obtained; and (iii) all data were
linked to first and second administrative units, based on
the United Nations’ Second Administrative Level Bound-
aries (SALB) database [76] and the GADM version 2 data-
base of Global Administrative Areas [77].
Geo-positioning of survey data
A decision-based algorithm (Figure 1) was applied to deter-
mine the longitude and latitude of survey locations,
using a variety of gazetteers: Bing Maps [78], GeoNet
Names Server [79], Fuzzy gazetteers [80] and the Open
Street Map project [81]. Geographical coordinates provided
Figure 1 Decision-based algorithm for the geopositioning of community surveys. This algorithm was developed to ensure the maximum
level of accuracy when geopositioning survey data. Briefly, when longitude and latitude of a survey site were provided by a publication, they
were cross-checked against a range of cartographic resources, including NGA GEOnet Names server (http://earth-info.nga.mil/gns/html/), Bing
maps (http://www.bing.com/maps/), Fuzzy Gazetteer/ISODP project (http://isodp.hof-university.de/fuzzyg/query/) and OpenStreetMap (http://
www.openstreetmap.org/). The same resources were used to geoposition surveys for which coordinates were not provided.
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by source publications were cross-checked against these
resources. The reliability of geopositioning was established
on a scale of 0 to 4, ‘0’ being no coordinates found, ‘1’
highly reliable, ‘2’ fairly reliable (spelling differences in 1 or
2 characters), ‘3’ less reliable (spelling differences in various
characters) and ‘4’ highly unreliable when less than 60% of
name similarity in gazetteers or when located in nearby
sites. All geographic coordinates were standardized to
decimal degrees in order to be displayed in the WGS84
geographic coordinate system. Ideally, surveys were lo-
cated to a point location but in certain instances surveys
were located to a wide-area polygon (10-25 km2 area), and
then the centroid of the polygon used.
Environment and demographic covariates
Geolocated prevalence data were linked to a range of
environmental and climatic variables which are known
to affect the development and survival of LF parasites
and its mosquito-vector species [82-86] (Table 1). These
data included mean, minimum and maximum estimates
of temperature and precipitation at 1 km2 resolution
obtained from WorldClim database [87]. Elevation data
at 1 km resolution were derived from gridded digital
elevation models (DEM) produced by the Shuttle Radar
Topography Mission (SRTM). An aridity index, which is
a generalized function of precipitation, temperature, and/
or potential evapotranspiration, was obtained at 1 km
resolution from CGIAR-CSI [88]. Estimates of averaged
enhanced vegetation index for period 1981 to 2006
were derived from imagery obtained from the Advanced
Very High Resolution Radiometer (AVHRR) instrument
onboard the NOAA satellites series, available from the
data library of the International Research Institute for
Climate and Society at Columbia University (IRI) [89].
Land cover data were obtained from the GlobCover
project [90] which comprises 22 land cover classes,
which we aggregated into seven major classes poten-
tially relevant to the eco-epidemiology of LF: agricul-
tural lands, forest areas, shrubland, grasslands and
woodlands, bare soil, urban areas, snow/ice and water
areas.
Estimates of population density were obtained from
the Gridded Population of the World (GPW) [91], which
was used to classify areas as urban, peri-urban or rural
areas, based on the assumption that urban extents (UE)
have a population densities ≥1,000 persons/km2, peri-
urban >250 persons/km2 within a 15 km distance from
UE edge, and rural <250 persons/km2 and/or >15 km
from the UE edge [92]. A gridded map of urban accessi-
bility 1 km resolution was obtained from the European
Commission Joint Research Centre Global Environment
Monitoring Unit (JRC) [93]. This dataset defined urban
accessibility as the predicted time taken to travel from
that grid cell to a city of ≥50,000 persons in the year
2000 using land- or water-based travel. Finally, a gridded
map at 5 km resolution of the main geographic regions
(Europe, Asia, Africa and America) was created. Western
Pacific countries were grouped upon the Asian region
whilst countries located in the Arabian Peninsula were
included within the African region.
Table 1 Description of environmental variables used to model the global distribution of lymphatic filariasis
transmission
Environmental variable Description
Mean minimum
temperature
Mean of average monthly minimum temperature across all 12 months (period 1950-2000)
Annual mean
temperature
Mean of average monthly mean temperature across all 12 months (period 1950-2000)
Precipitation in wettest
quarter
Total precipitation in the wettest quarter
Precipitation in driest
quarter
Total precipitation in the driest quarter
Annual precipitation Mean of accumulative precipitation across all 12 months (period 1950-2000)
Aridity Index Indicator of the degree of dryness of the climate at a given location, and result from dividing the mean annual
precipitation by the mean annual potential evapo-transpiration
Elevation Metres above the sea level obtained by radar imagery
EVI Mean of 8-day composite MODIS images for the period 2001 to 2005. EVI raw values (scale from 0 to 1) have been multiplied
by 1,000 for being storage as integers.
Global Land Cover 2006 A simplified version of seven major land cover classes obtained from the UN Global Land Cover (22 classes)
Population density
(1995-2015)
Average population density 1995-2015
WHO regions WHO regions: AFRO/EMRO (African and Eastern Mediterranean regions), AMRO (Americas region), SEARO (South-east Asia)
and WPRO (western Pacific)
Accessibility Cost (in time units) to access to large urban areas
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To bring the spatial resolution of these covariate layers in
line with the spatial accuracy of the survey data, covariates
were resampled to a common 5 km resolution raster layout
based on the WGS-1984 Web Mercator projection using
ArcGIS 10.1. (ESRI Inc., Redlands CA, USA). Bilinear
interpolation was applied to resample numeric (continuous)
raster data sets, whereas nearest neighbour interpolation
was used with ordinal raster layers. Possible collinearity be-
tween the covariates was explored using cross-correlations.
All correlation coefficients were less than 0.7, indicating
that covariates were largely orthogonal.
Predicting the probability of LF transmission using
boosted regression trees
Boosted regression trees (BRT) modelling was used for
mapping the spatial limits of LF transmission. This ap-
proach has been shown to have higher predictive accur-
acy than other distribution models [94] and has been
successfully applied to map dengue [95] and malaria vec-
tor mosquitoes [96]. BRT combines two machine learn-
ing approaches; regression trees (simple hierarchical
models which allow non-linear effects of predictors) and
boosting (fitting ensemble models by iterative improve-
ments on the existing ensemble [97,98]). A first step in
the BRT approach is the definition of occurrence and ab-
sence data. Records of disease occurrence were defined
as surveys during which one or more cases of LF were
detected, regardless of diagnostic method used. Absence
records were defined as surveys conducted prior to
large-scale control activities and from which no cases of
LF were reported. Because relatively few absence records
were available (prevalence surveys are typically carried
out in areas where disease presence is expected), these
data were supplemented with pseudo-absence records
following a similar procedure to that used for mapping
dengue and malaria vectors [93,94]. Five thousand pseudo-
absence data points were generated at random in areas
known not to be endemic for LF based on expert know-
ledge [14-20,99] or those areas considered as unsuitable
habitats for mosquito breeding - areas of bare and hyper-
arid land, as classified by the GlobCover [90] and Global
Aridity Index datasets [88]. In order to maximise the
ability of the model to discriminate between suitable
and unsuitable areas, regression weights were used
to down-weight pseudo-absence records, so that the
summed weights of the absence and pseudo-absence
records matched that of the presence records.
In the second stage, eight environmental variables
along with altitude, population density, accessibility and
macro-geographical regions were used to predict LF oc-
currence in a single BRT model, in order to explore the
relative importance of each factor in explaining the glo-
bal occurrence of LF (Table 1). Those factors that con-
tributed little (relative contribution <2%) to the single
BRT model were disregarded to build the final ensemble
BRT model. Thus, six covariates (precipitation in the
wettest quarter, annual minimum temperature, popula-
tion density 1990-2015, elevation, enhanced vegetation
index and regions) were subsequently selected and even-
tually used to build the final risk map.
In order to estimate uncertainty in the model and the
resulting risk maps, we finally fitted an ensemble of 120
BRT submodels, each fitted to a random bootstrap of
the full dataset. The predicted distributions of LF from
each of these submodels were then averaged to generate
the final risk map. Predictive performance of each sub-
model was evaluated using the following statistics: pro-
portion correctly classified (PCC), sensitivity (proportion
of presences correctly classified), specificity (proportion
of absences correctly classified), Kappa (k) and area
under the receiver operator characteristic (AUC). The
mean and confidence intervals for each statistic were
used to evaluate the predictive performance of the en-
semble BRT model. Marginal effect curves were plotted
to visualise dependencies between the probability of LF
occurrence and each of the covariates. These show the
marginal effect of each covariate on the response after
averaging the effects of all other covariates. Finally, the
relative contribution of each covariate (the percentage of
tree branches in each submodel that used the covariate)
to the final BRT model was also quantified.
Defining limits of transmission
The resulting predictive map quantifies the environmental
suitability for LF transmission. In order to convert this
continuous metric into a binary map outlining the limits
of transmission, a threshold value of suitability was deter-
mined, above which transmission was assumed to be pos-
sible. Based on the receiver operating characteristic curve,
a threshold value of environmental suitability was chosen
which maximised the trade-off between sensitivity, specifi-
city and PCC. Whilst the resulting map delineates envir-
onmental suitability for LF transmission, it may include
areas where transmission does not actually occur, due ei-
ther to the disease never having been imported into the
area or the consequence of control leading to local elimin-
ation. To reflect this, we masked the environmental distri-
bution map to remove areas which are known to be
currently non-endemic according to WHO [39,100,101]
and other sources [20,40,41,44,99]. Non-endemicity was
considered when no cases had been reported for the last
10 years and transmission assessment surveys confirmed
the interruption of LF transmission.
Results
LF database
The search strategy identified 9,033 surveys, conducted
between 1902 and 2013 in 85 countries, which were
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eligible for inclusion. Summary characteristics of included
surveys are reported in Table 2. An extended version of
this table is additionally provided (see Additional file 1).
Data were identified for 35 of 37 current endemic coun-
tries of sub-Saharan Africa and Eastern Mediterranean
WHO-region (AFRO/EMRO); 9/9 from South East Asia
region (SEARO); 18/22 from western Pacific region
(WPRO); 4/4 from the Americas region (AMRO). Data
were also available for a further 17 countriesa where LF is
no longer endemic or where transmission has recently
been declared as interrupted. Current endemic countries
for which no data were available were Angola and Gabon,
in the AFRO region, and Cambodia, Lao People’s Demo-
cratic Republic, Niue, and North Korea, in the SEARO
and WPRO regions.
Of eligible surveys, 7,852 (87.1%) represented disaggre-
gated, community-based surveys of which 7,420 (94.3%)
could be geo-positioned: 6,442 to point locations and 978
to small areas, such as households with scattered distribu-
tions, small islands and small administrative areas. Data
extracted from published sources accounted for 53.2% of
included survey locations and were the main source of in-
formation in the SEARO and WPRO regions. Grey litera-
ture, which included country reports, GAELF reports and
other unpublished articles, accounted for 46.8% of survey
locations, and were the main source of data in the AFRO/
EMRO region. The majority (82.9%) of data points were
obtained through mapping or prevalence surveys, whereas
1,141 (15.4%) were sentinel site surveys and 16 transmis-
sion assessment surveys. Among mapping/prevalence sur-
veys, 609 (9.9%) surveys were obtained by lot quality
assurance sampling (LQAS), mostly conducted after 2000.
Finally, 110 surveys derive from a countrywide clinical sur-
vey in Thailand, 1949-1950, where lymphoedema of lower
Table 2 Characteristics of surveys included in the lymphatic filariasis database
WHO - regions& AFRO/EMRO SEARO WPRO AMRO Total
N (%) N (%) N (%) N (%) N (%)
Current endemic countries 37 9 22 4 72
Countries with data 35 9 25 16 85
Number of surveys identified 5,468 1,764 1,322 479 9,033
Non-community data 673 (12.3) 246 (13.9) 201 (15.2) 43 (9.0) 1,163 (12.9)
Geopositioned 4,624 (84.6) 1,320 (74.8) 1058 (80.0) 418 (87.3) 7,420 (82.1)
Not geopositioned 171 (3.1) 198 (11.2) 63 (4.8) 18 (3.8) 432 (5.0)
Indicators concerning to community-level geopositioned surveys
Surveys by period
before 1990 1,157 (25.0) 688 (52.1) 774 (73.2) 316 (75.6) 2,935 (39.6)
1990-2000 441 (9.5) 146 (11.1) 116 (11.0) 70 (16.7) 773 (10.4)
2000-2010 2,040 (44.1) 486 (36.8) 159 (15.0) 32 (7.7) 2,717 (36.6)
2010-now 937 (20.3) - 9 (0.9) - 946 (12.7)
Unknown 49 (1.1) - - - 49 (0.7)
Type of survey
Mapping/prevalence 3,875 (83.8) 924 (70.0) 954 (90.2) 400 (95.7) 6,153 (82.9)
SS/Spot check 749 (16.2) 280 (21.2) 94 (8.9) 18 (4.3) 1,141 (15.4)
TAS - 6 (0.5) 10 (0.9) - 16 (0.2)
Passive recording - 110 (8.3) - - 110 (1.5)
Diagnostic method
Clinical 24 (0.5) 119 (9.0) 5 (0.5) 1 (0.2) 149 (2.0)
Parasitological 1,939 (41.9) 1,086 (82.3) 892 (84.3) 370 (88.5) 4,287 (57.8)
Serological 2,423 (52.4) 69 (5.2.) 114 (10.8) 30 (7.2) 2,636 (35.5)
Other 238 (5.1) 46 (3.5) 47 (4.4) 17 (4.1) 348 (4.7)
MDA Implemented
Unknown 19 (0.6) 36 (2.7) - 18 (4.3) 84 (1.1)
Pre-intervention 3,918 (84.7) 827 (62.7) 558 (52.7) 312 (74.6) 5,615 (75.7)
Post-intervention 676 (14.6) 457 (34.6) 500 (47.3) 88 (21.1) 1,721 (23.2)
&AFRO - African Regional Office, AMRO - Americas Regional Office, EMRO - Eastern Mediterranean Regional Office, SEARO - South East Asian Regional Office,
WPRO - Western Pacific Regional Office.
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limbs were recorded upon systematic population screening
by headmen of cantons [102] - this survey was included as
it provided the best nationwide data on occurrence for
Thailand.
Figures 2 and 3 show the geographical distribution of
survey locations by time period and by diagnostic method,
respectively. The date of surveys varied between regions.
The majority (71.9%) of data gathered for the AFRO/
EMRO region were collected post-2000, whilst for other
regions much of the available data were collected pre-
2000. Parasitological-based diagnosis accounted for 92.04%
of surveys before 2000, whereas 63.8% of the 4,065 surveys
undertaken after 2000 used serological tests. Only 348
(4.7%) surveys used two or more diagnostic methods.
Figure 2 The global distribution of data points included in the Global Atlas of Lymphatic Filariasis database by period of time. Red = surveys
undertaken post- 2000 when GFLEP was launched, and blue = before 2000. Current endemic countries are displayed in white, non-endemic countries in
grey and hatching depicts countries where endemicity is uncertain.
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Factors associated with LF transmission
A subset of 6,562 surveys (4,933 occurrences and 1,629
absences) available in the assembled LF database along
with the generated pseudo-absence data (5,000) were used
to model the global distribution of LF. Figure 4 shows the
marginal effect of each variable on the response, averaging
across the effects of all other variables, and its relative
contribution to the final BRT model. High suitability for
LF is positively associated with precipitation in the wettest
quarter (reaching a plateau at rainfall greater than
1000 mm), increased vegetation cover, population dens-
ity and minimum temperature (increasing from a mini-
mum value of 10°C), and negatively associated with
increasing elevation (Figure 4).
Global LF transmission map
Figure 5A presents the global map of environmental
suitability for LF transmission and suggests that this
Figure 3 The global distribution of data points included in the Global Atlas Lymphatic Filariasis database by diagnostic method.
Red = parasitological methods; blue = serological methods; and yellow = combination of methods.
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Figure 4 Marginal effect curves for each covariate used in the ensemble of 120 boosted regression tree (BRT) models. Black lines
represent the mean marginal effect over all 120 BRT ensembles and grey envelopes the 95% bootstrap confidence interval. The y-axis is the
untransformed logit response and x-axis is the full range of covariates values. The percentage values in parenthesis show the mean relative
contribution of the covariate over all 120 sub-models of the ensemble.
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suitability occurs primarily in tropical and sub-tropical
regions, with the highest suitability in parts of Central
and Latin America, West Africa, coastal east and south-
ern Africa, India, Southeast Asia, Indonesia, Papua New
Guinea and western Pacific. Validation statistics indi-
cated high predictive performance of the BRT ensemble
model with area under the receiver operating character-
istic (AUC) of 0.81 (95% CI: 0.78 – 0.83; sd: 0.01). An
environmental suitability threshold of 0.36 provided the
best discrimination between presence and absence re-
cords (Figure 6) and this threshold value was used to
classify the environmental suitability map into a binary
map of the environmental limits of transmission. This
map and the map of the current transmission limits (ex-
cluding areas known to be non-endemic) are shown in
Figure 5.
Figure 5 Global environmental suitability (A) and limits (B) of lymphatic filariasis transmission as predicted by the final boosted
regression trees model. Countries that have never reported LF endemic infections are masked in grey, and areas suitable for LF transmission, as
predicted by the BRT model, are displayed in red (B).
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LF transmission by region
Figures 7, 8 and 9 present the observed occurrence and
absence of LF and environmental suitability for LF trans-
mission for each region. In Africa, LF transmission is pre-
dicted to occur across much of coastal and savannah West
Africa (Figure 7) but is restricted mainly to the coastal
areas of east and southern Africa. The predicted distribu-
tion in central and southern Africa is uneven, with large
foci in northeast of South Sudan (Upper Nile and Jonglei),
Uganda, eastern Democratic Republic of Congo (Bas
Congo, Bandundu and Equateur provinces), southeast
Zambia and southern Malawi.
In the Americas region, LF transmission is predicted
to occur throughout north and north-east regions of
South-America, Central America, major islands in the
Caribbean region (Haiti and the Dominican Republic)
and marginally in coastal areas of southern United States
(Figure 8). LF has been eliminated from 20 countries in
the Americas region, and known current endemicity is
restricted to Brazil, Guyana and the Hispaniola (Dominican
Republic and Haiti) [99].
In Asia and western Pacific, LF transmission is predicted
to occur in the east of India, Sri Lanka, much of Southeast
Asia and southeast China, Papua New Guinea, the northern
coast of Australia and southern Japan (Figure 9). LF has
been eliminated in China (2007), Japan (1980s) and South
Korea (2008), but the predicted environmental suitability
corresponds well with the known historical, pre-control dis-
tribution [11,17,20] (Figure 10).
Discussion
Here we present a first global map of the distribution and
transmission limits of LF. This work is opportune as it pro-
vides a basis for tracking and interpreting progress in con-
trol over time and can define the pre-control transmission
limits, which, in turn, can inform the intensity and duration
of control [2,103]. Our work additionally provides insight
to post-MDA surveillance by identifying areas of highest
transmission which may be more prone to the resurgence
of transmission following cessation of interventions.
In the current analysis we identify the environmental
limits of potential transmission. We demonstrate that the
probability of LF transmission increases with increasing
precipitation, temperature and certain vegetation types but
decreases with increasing altitude (Figure 4). These find-
ings are consistent with previous analyses of environmental
correlates at continental [49,50] and country [52,104,105]
scales and are, undoubtedly, linked to temperature-related
variation in vector survival and parasite development
within the vector [82,84,85,106]. Our risk map, developed
using boosted regression tree modelling, shows that the
environmental conditions suitable for LF transmission
Figure 6 Receiver Operating Characteristics curve for the occurrence of LF transmission and associated model validation statistics:
AUC = 0.81 (95% CI: 0.78 – 0.83; sd: 0.01), sensitivity = 0.73 (95% CI: 0.64 – 0.79; sd: 0.02), specificity = 0.76 (95% CI: 0.7 – 0.83; sd:
0.02), proportion correctly classified (PCC) = 0.75 (95% CI: 0.72 – 0.78; sd: 0.01) and Kappa = 0.5 (95% CI: 0.44 – 0.56; sd: 0.02). The
environmental suitability threshold which provided the best trade-off between sensitivity, specificity and proportion of correctly classified
was 0.360.
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occurs throughout the forest and savannah regions of West
Africa, coastal east Africa and Madagascar and restricted
foci in central and southern Africa. Suitable environmental
conditions also occur across tropical areas of south and
South-east Asia and the Pacific as well as large areas of
Central and South America, including the southern States
of America. Interestingly, however, active transmission in
Central and South America is restricted to isolated foci;
the possible reasons for this discrepancy are discussed
below. Our predictions of environmental suitability in tem-
perate regions are consistent with documented historical
distributions prior to large scale intervention and local
elimination in Japan, South Korea, and southern China
[15-19] (Figure 10), the north coast of Australia [107] and
southeastern coast of United States [99].
The probability of LF transmission is additionally as-
sociated with population density. Such an association
probably reflects differences in the distribution of differ-
ent vector species and their habitat preference and sus-
ceptibility to LF [108-110]. In rural areas of Africa, LF is
transmitted by Anopheles species, whereas in urban set-
tings in east Africa and the Nile Delta transmission is by
Culex quinquefasciatus [111,112]. In West Africa, Culex
mosquitoes, although widely distributed [113], are con-
sidered refractory to infection [114-116], although some
studies have demonstrated compatibility between West
African strains of W. bancrofti and Culex and Mansonia
mosquitoes [117-120]. Culex transmission also occurs
in Asia [121-126] and Culex quinquefasciatus is the only
vector known in the Americas [127,128]. The true extent
of LF transmission in urban settings, especially in sub-
Saharan Africa, remains poorly documented [30,129,130],
and further work is warranted.
Our work provides interesting insight into the re-
gional distributions of LF. In sub-Saharan Africa, LF
transmission is highly heterogeneous (Figure 7), with
the highest potential risk in the forest and savannah re-
gions of West Africa and coastal areas of eastern Africa
and Madagascar. Scattered and relatively small areas of
high-moderate risk are predicted in central Africa. This
distribution of LF across Africa corresponds well with
the known historical distribution of LF on the continent
[17,18] and predicts transmission in countries which
have yet to be extensively mapped, such as Gabon [131]
Figure 7 Reported and predicted distribution of lymphatic filariasis in Africa. (A) Observed occurrence and absence of LF and (B)
environmental suitability for lymphatic filariasis transmission, as predicted by the final boosted regression trees model, in Africa.
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or Angola [132]. Our predictions indicate a more geo-
graphically restricted distribution of LF (Figure 7) than
earlier spatial predictions using environmental factors
[49,50]. Our analysis included some 4,624 surveys
across most endemic countries in Africa, whereas previ-
ous analysis [49,50] included fewer than 700 surveys
which were mainly concentrated in West Africa, Egypt,
Sudan, Kenya, Tanzania and Madagascar; studies which
were typically conducted in known areas of transmis-
sion. Such paucity and biased clustering of data coupled
with the use of regression-based modelling will result in
the smoothing of prevalence across large areas and
overestimate prevalence in unsurveyed areas [133,134].
Our use of BRT modelling overcomes the geographical
bias of data by the use of pseudo absences [135], which
are randomly generated from areas known to be unsuit-
able for mosquito breeding or non-endemic for LF.
Our risk map predicts widespread environmental suit-
ability of LF in Central and South America, whereas ac-
tive transmission is known to occur only in isolated foci
[136]. We suggest two possible reasons for this discrep-
ancy. First, historically, LF occurred across 20 countries
and territories in the region [19,99], including islands of
the Caribbean and coastal areas of southeast Unites
States, where indigenous cases were reported as far
north as Philadelphia, until 1930s [99]. A combination
of intensive vector control and improvements in public
sanitary works resulted in the local elimination in these
settings. Second, the transmission of LF in the Americas
is strongly influenced by historical socioeconomic and
demographic factors, rather than environmental factors.
Transmission of LF was introduced to the Americas by
slaves transported from West Africa to work in sugar-
cane plantations during the 17th and 18th centuries
[137]. Initially, large numbers of slaves were brought to
Barbados and Brazil, and subsequently sent to other
islands of the Caribbean, to the north American colonies
(South Carolina and Virginia) and northern countries of
South America (Venezuela, Guyana, French Guiana, and
Suriname) [17,19,99]. Upon introduction, W. bancrofti
readily adapted from transmission by African Anopheles
mosquitoes to transmission by Culex mosquitoes com-
monly found in the overcrowded and insanitary towns
and cities of the Americas. However, it appears that
Figure 8 Reported and predicted distribution of lymphatic filariasis in the Americas. (A) Observed occurrence and absence of LF and (B)
environmental suitability for lymphatic filariasis transmission, as predicted by the final boosted regression trees model, in the Americas.
Cano et al. Parasites & Vectors 2014, 7:466 Page 13 of 19
http://www.parasitesandvectors.com/content/7/1/466
transmission has remained restricted to those areas where
the disease was firstly introduced. In settings where socio-
economic and sanitary conditions have improved and in-
terventions have been implemented in recent decades, the
disease has gradually disappeared, for example in the
Caribbean region [138]. In those countries with active
transmission today - Brazil, the Dominican Republic,
Guyana and Haiti [39,139], infection occurs mainly in
urban settings and is strongly associated with poor socio-
economic conditions [140-142]. Future work will explore
the interplay of environmental, socioeconomic factors and
coverage of interventions on the distribution and preva-
lence of LF.
The distribution of LF in Asia exhibits marked regional
trends. In India, high transmission occurs across the
northern Indian (Gangetic) plain which borders Nepal and
Bangladesh, eastern and south western coastal areas, areas
in the central Deccan region in the south and on the
Andaman and Nicobar Islands (Figure 9). Moderate-low
transmission occurs in inland areas of southwestern
India. Such a distribution is consistent with previous
district-level mapping [143] (Figure 10D) and a previous
national-level environmental risk model [104]. The pre-
dicted environmental limits for China, Japan and South
Korea correspond well with the historical distribution
prior to large control and local elimination [20,144,145]
(Figure 10A-B). Although LF has been declared eliminated
in China, the vectors remain and occasional imported
cases have been reported [146], so that long-term surveil-
lance is required to ensure that recrudescence does not
occur. In contrast to the predictions for India and east
Asia, our environmental-based map overestimates risk
in the southeast Asian countries of Vietnam, Cambodia,
Thailand and PDR Laos, which are considered to have
limited transmission [147]. In Thailand, B. malayi trans-
mission occurs in the south of the country [102] and W.
bancrofti is endemic in the western provinces bordering
Myanmar [148], but control measures implemented since
the 1960s have dramatically reduced transmission [102].
We have sought to conduct an exhaustive search assem-
bly of historical and contemporary data on LF occurrence
and prevalence and have used rigorous methodology to
Figure 9 Reported and predicted distribution of lymphatic filariasis in South-Asia and Western Pacific. (A) Observed occurrence and
absence of LF and (B) environmental suitability for lymphatic filariasis transmission, as predicted by the final boosted regression trees model, in
South-east Asia and western Pacific.
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predict the occurrence of LF transmission, but recog-
nise a number of limitations. The BRT model presented
here is driven by environmental parameters and spatial
configuration of habitats that allow persistence of species
in landscapes. This modelling approach has been applied
successfully to map the distribution of mosquito-borne
diseases, such as dengue and malaria, which are transmit-
ted by one mosquito genera with limited species diversity
within geographical regions [96,149]. LF is unique among
mosquito-borne diseases because it is transmitted by mos-
quito species belonging to five genera: Aedes, Anopheles,
Culex, Mansonia and Ochlerotatus. In Africa, where LF is
transmitted principally by Anopheles species, the disease
distribution corresponds well with the known historical
distribution patterns across the continent. This is not
surprising because the environmental factors determining
the abundance and distribution of Anopheles mosquitoes
across Africa have not changed much in the peri-domestic
environment in the past 20 years. However, our model
performs less well in areas where LF is transmitted by
Culex mosquitoes, especially Culex quinquefasciatus,
which is predominately an urban mosquito with breeding
habits that are influenced more by human activity than
environmental factors [150,151]. It follows, therefore, that
environmental factors impact on transmission differently
for different mosquito species. For example, precipitation,
an important determinant in our environmental model, it
likely to affect Anopheles and Culex species differently.
While frequent rainfall generally tends to increase the
densities of adult mosquitoes by producing breeding sites,
their densities may be reduced by the flushing of sites
when precipitation is high. It may be that anopheline and
culicine mosquitoes differ in their response to heavy rain-
fall since they breed in different habitats. In areas suitable
for transmission by Culex quinquefasciatus, human fac-
tors, such as sanitary and housing conditions, may play an
important role in transmission. Our model may have
therefore overestimated the current limits for LF in Culex-
transmitted areas.
We additionally recognise the limitations of the current
empirical evidence base, especially in regard to unpub-
lished surveys that found an absence of transmission. We
did not perform age correction of prevalence data since
our current focus was on the occurrence of transmission.
Figure 10 Comparison of known historical distribution (A, D) and modelled distribution (B, C) in China and India. (A) Historical
distribution of LF in China (1950-1970) modified from Kimura et al. [20] and (D) district-level endemicity map in India based on historical data
(prior to 2000) from Sabesan et al. [143].
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For similar reasons we did not adjust for differences in sen-
sitivity of various diagnostic methods [152]. Future work
will seek to model the prevalence of LF infection and will
take into account such differences in age patterns and diag-
nostic method. Finally, our study focused on the environ-
mental limits of LF transmission and, as discussed above,
we recognise our model does not capture the socioeco-
nomic and intervention-related dynamics of transmission.
This is the subject of ongoing work investigating the spatio-
temporal distribution of LF and the degree to which
changes are related to the scaling-up of interventions or
other factors.
Conclusions
Despite the limitations and caveats acknowledged above,
the assembled database represents a unique resource and
the global map provides the best currently available indica-
tion of the global distribution of LF, past and present. Con-
sistent with the open access approach of the Global Atlas
of Helminth Infection, the assembled data and developed
maps are publicly available (www.thiswormyworld.org). As
the global LF community moves towards elimination, the
assembled data maps and model predictions will help track
progress and increase the cost-effectiveness of surveillance
activities post-control.
Endnotes
aAFRO/EMRO region: Seychelles and Mayotte; AMRO
region: Antigua & Barbuda, Costa Rica, Cuba, French
Guiana, Martinique, Puerto Rico, Saint Lucia, Saint Vin-
cent and the Grenadines, Suriname, Trinidad & Tobago,
Venezuela and Virgin Islands, United States of America;
and WPRO region: Cook Islands, Palau and Solomon
Islands.
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